Severe irreversible bilateral hearing loss after bortezomib (VELCADE®) therapy in a multiple myeloma (MM) patient

被引：14
|
作者：
Engelhardt, M
Müller, AMS
Maier, W
Wäsch, R
机构：
[1] Univ Med Ctr, Dept Hematol & Oncol, D-79106 Freiburg, Germany
[2] Univ Freiburg, Dept Otolaryngol, D-7800 Freiburg, Germany
来源：
LEUKEMIA | 2005年 / 19卷 / 05期
关键词：
D O I：
10.1038/sj.leu.2403723
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：869 / 870
页数：2
相关论文
共 50 条
  • [31] Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma
    Rena Morita
    Satoshi Hashino
    Shinichi Shirai
    Noriaki Fujita
    Masahiro Onozawa
    Kaoru Kahata
    Takeshi Kondo
    Masahiro Imamura
    Masahiro Asaka
    International Journal of Hematology, 2008, 88 : 248 - 250
  • [32] Guillain Barre Syndrome in a multiple myeloma patient after the first course of bortezomib therapy: A case report
    Dai, Xingbin
    Sun, Xuemei
    Ni, Haiwen
    Zhu, Xuejun
    ONCOLOGY LETTERS, 2015, 10 (05) : 3064 - 3066
  • [33] Severe Heart Failure after Using Bortezomib in a Patient with Multiple Myeloma and Cardiac Amyloidosis of Normal Wall Thickness
    Kao, Ting -Wei
    Huang, Tai -Chung
    Liao, Che-Wei
    Shun, Chia -Tung
    Tsai, Cheng-Hsuan
    Lin, Yen -Hung
    ACTA CARDIOLOGICA SINICA, 2024, 40 (04) : 454 - 457
  • [34] Bortezomib (Velcade™) plus Adriamycin™ plus thalidomide plus dexamethasone (VATD) as an effective regimen in patients with refractory or relapsed multiple myeloma (MM)
    Hollmig, K
    Stover, J
    Talamo, G
    Fassas, A
    Lee, CK
    Anaissie, E
    Tricot, G
    Barlogie, B
    BLOOD, 2004, 104 (11) : 659A - 659A
  • [35] RENAL FAILURE IS REVERSIBLE AFTER THERAPY WITH BORTEZOMIB IN PATIENTS WITH MULTIPLE MYELOMA
    Goranova-Marinova, V.
    Nedeva, A.
    Nikolov, I.
    Georgiev, P.
    Hristova, I.
    Gigov, I.
    Raynov, J.
    Goranov, S.
    HAEMATOLOGICA, 2013, 98 : 602 - 603
  • [36] Bortezomib(Velcade®)-Thalidomide-Dexamethasone (VTD) Is Superior to Thalidomide-Dexamethasone (TD) In Patients with Multiple Myeloma (MM) Progressing or Relapsing After Autologous Transplantation.
    Garderet, Laurent
    Iacobelli, Simona
    Moreau, Philippe
    Dib, Mamoun
    Caillot, Denis
    Niederwieser, Dietger W.
    Masszi, Tamas
    Fontan, Jean
    Michallet, Mauricette
    Gratwohl, Alois
    Milone, Giuseppe
    Doyen, Chantal
    Pegourie, Brigitte
    Hajek, Roman
    Casassus, Philippe
    Kolb, Brigitte
    Chaleteix, Carine
    Hertenstein, Bernd
    Onida, Francesco
    Ludwig, Heinz
    Vekemans, Marie Christiane
    Ketterer, Nicolas
    Daguenel, Anne
    Gorin, Norbert C.
    Harousseau, Jean Luc
    de Witte, Theo
    Morris, Curly
    Gahrton, Gosta
    BLOOD, 2010, 116 (21) : 1254 - 1254
  • [37] A phase II multicenter randomized study of the proteasome inhibitor bortezomib (VELCADE™, formerly PS-341) in multiple myeloma (MM) patients (pts) relapsed after front-line therapy.
    Jagannath, S
    Barlogie, B
    Berenson, J
    Siegel, D
    Irwin, D
    Richardson, PG
    Alexanian, R
    Limentani, SA
    Alsina, M
    Lee, S
    Esseltine, DL
    Kauffman, M
    Adams, J
    Schenkein, DP
    Anderson, KC
    BLOOD, 2002, 100 (11) : 812A - 812A
  • [38] Successful therapy with bortezomib for erradication of inhibitor in a patient with multiple myeloma and acquired hemophilia A
    Fernandes, S. N.
    Carvalho, M.
    Lopes, M.
    Pinto, R.
    Bergantim, R.
    Guimaraes, J. E.
    Araujo, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 758 - 758
  • [39] Tuberculosis meningitis in patient with multiple myeloma during bortezomib-containing therapy
    Tsai, Yu-Chen
    Wang, Hui-Ching
    Hsiao, Hui-Hua
    Liu, Ta-Chih
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2016, 32 (10): : 531 - 532
  • [40] Initial Treatment with Bortezomib (Velcade®), Doxil®, and Dexamethasone (VDD) Is Superior to Thalidomide and Dexamethasone (TD) as Initial Therapy Prior to Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma (MM)
    Jakubowiak, Andrzej
    Kendall, Tara
    Al-Zoubi, Ammar
    Khaled, Yasser
    Mineishi, Shin
    Brozo, Christine
    Campagnaro, Erica
    Talpaz, Moshe
    Kaminski, Mark S.
    BLOOD, 2008, 112 (11) : 1273 - 1273
12345